Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine vs Conventional Induction Intubation in ICU Patients
NCT05464979Phase 1Completed
- Start
- Aug 2022
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of esketamine in critical illness (2 arms). Primary endpoints: Mean Arterial Pressure at 60 months, Heart Rate at 60 months and 1 more. Started Aug 2022; status: completed.
02
Drugs
esketamine
03
Conditions
critical illness
Beyond the preview
Go deeper on NCT05464979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05464979.